BioPharmaSpec Announces Major Investments in Mass Spectrometry and Related Instrumentation

The state-of-the-art instrumentation will support and accelerate BioPharmaSpec’s clients’ efforts in successful biologics product development MALVERN, Pa. and ST. SAVIOUR, Jersey, June 03, 2024 (Korea Bizwire) — BioPharmaSpec (“BioPharmaSpec”), the leading global Contract Research Organization (CRO) for discovery and preclinical characterization of biopharmaceuticals, has made major new investments in instrumentation, including top-of-the-range Mass Spectrometers, to [...]